Status:
NOT_YET_RECRUITING
Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes
Lead Sponsor:
University Hospital, Motol
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
11-19 years
Phase:
NA
Brief Summary
The proposed project is a clinical intervention trial testing the feasibility and effectiveness of diabetic retinopathy screening evaluated by artificial intelligence (AI) based software in children w...
Eligibility Criteria
Inclusion
- Type 1 diabetes diagnosed according to the ADA criteria
- Age over 11.0 years or duration of diabetes over 2 years
- Signed written informed consent by both the CwD and their parent/caregiver
Exclusion
- Unwillingness to sign a written informed consent by both the CwD and their parent/caregiver
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07149142
Start Date
January 1 2026
End Date
December 31 2029
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Motol
Prague, Prague 5, Czechia, 15006